AQR Capital Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
VPM
VCM
AIM
AQR Capital Management's VCYT Position: Q1 2026 in Review
AQR Capital Management increased its Veracyte (VCYT) stake by 219% in Q1 2026, buying an estimated $2.3M and bringing the position to 90,322 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2105.
AQR Capital Management first reported a position in VCYT in Q1 2019 and has held it in 26 quarters since. The position peaked at $11.7M in Q2 2019. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- AQR Capital Management held 90,322 shares of Veracyte worth $2.91M as of Q1 2026.
- AQR Capital Management bought 62,029 Veracyte shares in Q1 2026, an estimated $2.3M.
- Veracyte made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2105 holding.
- AQR Capital Management first reported a position in Veracyte in Q1 2019 and has held it in 26 quarters since.
- AQR Capital Management's Veracyte position peaked at $11.7M in Q2 2019.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.